Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

285.95 USD -0.67 (-0.23%)
Streaming Delayed Price Updated: 3:38 PM EDT, Sep 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
Eisai Co Ltd(OTC: ESALY)began its application processfor lecanemab (BAN2401) for early Alzheimer's disease ... 
Tags ESALF FDA Biotech
From Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ESALY EBS AMZN
From Benzinga
Is Cassava Sciences Back in the Game?
There's nothing spectacular about the latest results for the company's flagship drug. 
Tags BIIB Market News SAVA
From Motley Fool
Benzinga's Bulls And Bears Of The Week: Apple, Bitcoin, Disney, Microsoft And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls ... 
Tags Trading Ideas Nike Benzinga
From Benzinga
Noteworthy Friday Option Activity: M, KMPH, BIIB
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Macy's Inc (M), where a total of 75,713 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
It's been about four months since Biogen, Inc. (NASDAQ: BIIB) received approval for its controversial Alzheimer's treatment ... 
Tags Biotech Aduhelm Benzinga
From Benzinga
Biogen Stock Pops, But D.C. Center Bans All — Not Just Aduhelm — Sales Reps
Biogen stock jumped Thursday on a fresh buy rating even as the controversy surrounding Alzheimer's drug Aduhelm deepened. 
From Investor's Business Daily
Where Biogen Stands With Analysts
Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following analyst ratings: Bullish Somewhat ... 
Tags Analyst Ratings Market News BIIB
From Benzinga
Nasdaq 100 Movers: PDD, BIIB
In early trading on Thursday, shares of Biogen (BIIB) topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.1%. Year to date, Biogen registers a 21.9% gain. 
Tags Stocks
From Market News Video
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:WMG) from Equal-Weight to Overweight. ... 
Tags INCY VIPS JAZZ
From Benzinga
Thinking About Buying Stock Or Options In Tesla, Ballard Power, Bloom Energy Or Biogen?
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created ... 
Tags Price Target Analyst Ratings BE
From Benzinga
Apple Working On iPhone Features To Detect Depression, Cognitive Decline: Report
Apple, Inc. (NASDAQ: AAPL) isreportedly nurturing serious ambitions to expand its presence in the health care ... 
Tags AAPL BIIB General
From Benzinga
Is Now the Time to Ditch Pharma Stocks?
With drug pricing reform on the horizon, investors may want to analyze their allocation. 
Tags VTRS VRTX BHC
From Motley Fool
With Prothena Up Over 500% This Year, Is It Too Late to Get in?
Promising drug candidates could lead to a best-in-class Alzheimer's treatment. 
Tags RHHBY Market News NVO
From Motley Fool
Notable Friday Option Activity: FE, BIIB, SIVB
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in FirstEnergy Corp (FE), where a total of 18,576 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CRDL GRTS TYRA
From Benzinga
Expert Ratings For Biogen
Over the past 3 months, 7 analysts have published their opinion on Biogen (NASDAQ:BIIB) stock. These analysts are typically employed by ... 
Tags Analyst Ratings Market News BIIB
From Benzinga
Biogen Reports Mixed Phase 2 Data For Its Non-Opioid Pain Candidate
Biogen Inc(NASDAQ: BIIB) hasannounced topline resultsfrom its Phase 2 CONVEY study of vixotrigine (BIIB074) for ... 
Tags Market News General BIIB
From Benzinga
Biogen Launches High-Dose Spinraza Trial In Evrysdi Treated Patients: What You Need To Know
Biogen Inc's(NASDAQ: BIIB) Spinraza (nusinersen), spinal muscular atrophy (SMA) drug launched in early 2017, faces new ... 
Tags Biotech RHHVF RHHBY
From Benzinga
First Week of BIIB September 17th Options Trading
Investors in Biogen Inc (BIIB) saw new options become available this week, for the September 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options... 
Tags Stocks
From Market News Video
3 Quality Stocks to Buy From the Bargain Bin
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Markets are coming out of a slightly red week. Sentiment has soured, so that leaves the door open to find good stocks to buy cheaply. The... 
Tags DOCU Stocks to Buy Market News
From InvestorPlace
Cassava Stock Is a Bold Play That Could Pay Off Soon
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bears are attacking Cassava as it questions the quality of its clinical data and try to stop its study for treating Alzheimer’s disease.... 
Tags SAVA Stocks to Buy Market News
From InvestorPlace
Portfolio Review: Biogen & T. Rowe Price
Biogen reported second quarter sales declined 25% to $2.8 billion. T. Rowe Price reported strong second quarter results with revenues rising 36% to $1.9 billion. 
Tags Market News Healthcare Financial
From TalkMarkets
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
Biotech stocks retreated in the holiday-shortened week endingSept. 10, reversing course from the previous week. Humanigen, Inc. ... 
Tags CORT GRTS TYRA
From Benzinga
Why Biogen Stock Is Sinking This Week
The U.S. launch of Alzheimer's disease drug Aduhelm is off to a sluggish start. 
Tags BIIB Market News MS
From Motley Fool
Stock Market Closes Lower, But These Signs Suggest Restrained Selling
The stock market closed lower Thursday, although signs pointed to restrained selling and small caps rose. 
From Investor's Business Daily
Notable Thursday Option Activity: BIIB, BCOR, AMBA
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Biogen Inc (BIIB), where a total of 17,455 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
Why Biogen Shares Are Falling
Biogen Inc (NASDAQ: BIIB) shares are trading lower by 7% at $298.83 following reports the company's CEO highlighted a ... 
Tags News why it's moving BIIB
From Benzinga
Biogen Stock Dives As CEO Admits 'Slower Than We Anticipated' Alzheimer's Drug Launch
Biogen stock tumbled Thursday after its CEO admitted the launch of Alzheimer's drug Aduhelm has been "slower than we anticipated." 
From Investor's Business Daily
Why Biogen Stock Is Slipping Today
Aduhelm's commercial launch isn't off to a strong start. 
Tags MS Market News BIIB
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.